APA
PLRX icon

American Portfolios Advisors’s Pliant Therapeutics PLRX Stock Holding History

American Portfolios Advisors’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$4.18K Buy
+200
New +$3.83K ﹤0.01% 2893

Other funds holding PLRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

American Portfolios Advisors's PLRX Position: Q3 2022 in Review

American Portfolios Advisors opened a new position in Pliant Therapeutics (PLRX) in Q3 2022: 200 shares worth $4.18K. The stake represents ﹤0.01% of the portfolio and ranks #2893 among its holdings.

110 funds tracked by Wall St. Rank hold PLRX as of Q3 2022.

  • American Portfolios Advisors held 200 shares of Pliant Therapeutics worth $4.18K as of Q3 2022.
  • Pliant Therapeutics was a new American Portfolios Advisors position in Q3 2022.
  • Pliant Therapeutics made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2893 holding.
  • 110 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.